74 related articles for article (PubMed ID: 30362626)
1. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma.
Sheng JQ; Wang MR; Fang D; Liu L; Huang WJ; Tian DA; He XX; Li PY
Biomed Pharmacother; 2021 Jan; 133():111023. PubMed ID: 33378941
[TBL] [Abstract][Full Text] [Related]
3. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
[TBL] [Abstract][Full Text] [Related]
4. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
[TBL] [Abstract][Full Text] [Related]
5. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
6. Human Umbilical Cord Mesenchymal Stem Cells-derived Exosomal lncRNA FAM99B Represses Hepatocellular Carcinoma Cell Malignancy.
Xu G; Ban K; Mu H; Wang B
Mol Biotechnol; 2024 Jun; 66(6):1389-1401. PubMed ID: 37351835
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling.
Haga Y; Bandyopadhyay D; Khatun M; Tran E; Steele R; Banerjee S; Ray R; Nazzal M; Ray RB
J Biol Chem; 2024 May; 300(5):107247. PubMed ID: 38556083
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding ribonucleic acid W5 inhibits progression and predicts favorable prognosis in hepatocellular carcinoma.
Lei GL; Fan HX; Wang C; Niu Y; Li TL; Yu LX; Hong ZX; Yan J; Wang XL; Zhang SG; Ren MJ; Yang PH
World J Gastroenterol; 2021 Jan; 27(1):55-68. PubMed ID: 33505150
[TBL] [Abstract][Full Text] [Related]
9. The comprehensive roles of lncRNA FAM99A/FAM99B in hepatocellular carcinoma: Expressions, regulatory mechanisms and functional pathway analysis.
Jin H; Li Y; Qin S; Li Q; Mao Y; Zhao L
Life Sci; 2024 Jul; 349():122710. PubMed ID: 38740325
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
Li R; Zhang L; Jia L; Duan Y; Li Y; Bao L; Sha N
PLoS One; 2014; 9(6):e100893. PubMed ID: 24967732
[TBL] [Abstract][Full Text] [Related]
11. Design and Functional Validation of a Mutant Variant of the LncRNA
Battistelli C; Garbo S; Riccioni V; Montaldo C; Santangelo L; Vandelli A; Strippoli R; Tartaglia GG; Tripodi M; Cicchini C
Cancer Res; 2021 Jan; 81(1):103-113. PubMed ID: 33158813
[No Abstract] [Full Text] [Related]
12. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
Chen Y; Lin C; Liu Y; Jiang Y
Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
[TBL] [Abstract][Full Text] [Related]
13. Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.
Su T; Zhang N; Wang T; Zeng J; Li W; Han L; Yang M
Cancer Res; 2023 Dec; 83(24):4080-4094. PubMed ID: 37756562
[TBL] [Abstract][Full Text] [Related]
14. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C
Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606
[TBL] [Abstract][Full Text] [Related]
15. Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.
Kan G; Wang Z; Sheng C; Chen G; Yao C; Mao Y; Chen S
Adv Sci (Weinh); 2021 May; 8(10):2004344. PubMed ID: 34026451
[TBL] [Abstract][Full Text] [Related]
16. RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma.
Zhou J; Tu D; Peng R; Tang Y; Deng Q; Su B; Wang S; Tang H; Jin S; Jiang G; Wang Q; Jin X; Zhang C; Cao J; Bai D
Cell Commun Signal; 2023 Aug; 21(1):224. PubMed ID: 37626338
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J
Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456
[TBL] [Abstract][Full Text] [Related]
18. HOXB8 Counteracts MAPK/ERK Oncogenic Signaling in a Chicken Embryo Model of Neoplasia.
Wilmerding A; Bouteille L; Rinaldi L; Caruso N; Graba Y; Delfini MC
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445617
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling.
Shah AD; Bouchard MJ; Shieh AC
PLoS One; 2015; 10(11):e0142337. PubMed ID: 26560447
[TBL] [Abstract][Full Text] [Related]
20. Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Wagner MJ; Lyons YA; Siedel JH; Dood R; Nagaraja AS; Haemmerle M; Mangala LS; Chanana P; Lazar AJ; Wang WL; Ravi V; Holland EC; Sood AK
Sci Rep; 2021 Apr; 11(1):9362. PubMed ID: 33931674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
